US Broker Ratings

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unveiling a 163% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out in the biotechnology sector with its focus on developing treatments for rare and ultra-rare genetic diseases. With a current..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Biotechnology Innovator with 122.82% Potential Upside

Vera Therapeutics, Inc. (NASDAQ: VERA), a promising player in the biotechnology sector, has captured investor interest with its potential for substantial upside. As a clinical-stage company,..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Healthcare Diagnostics Landscape with a 27.74% Potential Downside

GRAIL, Inc. (NASDAQ: GRAL) stands at the forefront of the healthcare diagnostics industry, specializing in multi-cancer early detection testing and services. Headquartered in Menlo Park, California,..

Certara, Inc. (CERT) Stock Analysis: Exploring a 61.83% Potential Upside in the Healthcare Sector

Investors eyeing the healthcare sector might find Certara, Inc. (NASDAQ: CERT) an intriguing prospect, especially considering its significant potential upside of 61.83%. With a market cap..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Exploring a Potential 111.60% Upside

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a burgeoning player in the biotechnology industry, is making waves with its innovative eye-care therapies. With a market capitalization of $2.31..

Edgewise Therapeutics, Inc. (EWTX) Investor Outlook: Exploring a Potential 98% Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a burgeoning player in the biotechnology sector, offers intriguing opportunities for investors with its promising pipeline of therapies targeting muscle disorders...

Novavax, Inc. (NVAX) Stock Analysis: Navigating a Potential 81% Upside in Biotech

Novavax, Inc. (NASDAQ: NVAX), headquartered in Gaithersburg, Maryland, is a prominent player in the biotechnology sector, with a focus on developing innovative vaccines to combat serious..

ImmunityBio, Inc. (IBRX) Stock Analysis: A 372% Potential Upside in the Biotech Sector

ImmunityBio, Inc. (NASDAQ: IBRX) is capturing the attention of investors in the healthcare sector, particularly within biotechnology, thanks to its promising growth potential. With a market..

Veracyte, Inc. (VCYT) Stock Analysis: Riding the Diagnostics Wave with a 6.97% Upside

Veracyte, Inc. (NASDAQ: VCYT) stands at the forefront of the diagnostics and research industry, offering innovative genomic solutions that are reshaping cancer diagnostics. Headquartered in South..

Liquidia Corporation (LQDA) Stock Analysis: Exploring Growth Potential with a 54.89% Upside

Liquidia Corporation (NASDAQ: LQDA) is capturing the attention of investors in the biotechnology sector, driven by its significant growth potential and strategic focus on addressing unmet..

GeneDx Holdings Corp. (WGS) Stock Analysis: A 9.54% Upside in the Surging Genomics Market

GeneDx Holdings Corp. (NASDAQ: WGS) stands at the forefront of the genomics industry, carving out a niche in diagnostics and research, with a particular emphasis on..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a 116% Potential Upside

Investors looking for high-risk, high-reward opportunities in the biotechnology sector may find Beam Therapeutics Inc. (NASDAQ: BEAM) an intriguing prospect. With a market capitalization of $2.2..

PACS Group, Inc. (PACS) Stock Analysis: A 177% Upside Potential in the Healthcare Sector

PACS Group, Inc. (PACS) is emerging as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. Based in Farmington, Utah, the..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: 14.39% Potential Upside as Biotech Innovates in Hematology

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a prominent player in the biotechnology sector, is attracting investor attention with its innovative approach to treating rare hematological conditions. Headquartered..

Belite Bio, Inc (BLTE) Stock Analysis: Biotechnology Innovator with Promising Clinical Trials and High Analyst Confidence

Belite Bio, Inc (BLTE) is a biotech company making waves in the healthcare sector with its focus on developing novel therapeutics for retinal degenerative diseases. Headquartered..

Schrodinger, Inc. (SDGR) Stock Analysis: A 49% Potential Upside in the Innovative Health Information Services Sector

Schrodinger, Inc. (NASDAQ: SDGR) stands at the forefront of computational technology in the healthcare sector, demonstrating a compelling growth story that has captured the attention of..

Select Medical Holdings Corp (SEM) Stock Analysis: Unpacking a 35.98% Potential Upside in Healthcare

Select Medical Holdings Corporation (NYSE: SEM) stands out in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.65 billion,..

Artivion, Inc. (AORT) Stock Analysis: 14.97% Potential Upside Captivates Investors

Artivion, Inc. (NASDAQ: AORT), a key player in the medical devices industry, is capturing investor attention with a notable 14.97% potential upside. Headquartered in Kennesaw, Georgia,..

Twist Bioscience Corporation (TWST): Analyst Consensus and Potential Upside of 27.99% Sparks Investor Interest

Twist Bioscience Corporation (NASDAQ: TWST), a pioneering force in the healthcare sector specializing in diagnostics and research, is gaining traction among investors due to its promising..

SS Innovations International (SSII) Stock Analysis: Exploring a High-Growth Potential in Healthcare Robotics

SS Innovations International, Inc. (SSII) has been making waves in the healthcare sector, particularly in the medical devices industry. Headquartered in Gurugram, India, this commercial-stage surgical..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds